Sentinel node and survival in melanoma

British Journal of Dermatology

Volumn 153, Issue 6, 2005, Pages 1093-1095

  Russell Jones, R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; CANCER RECURRENCE; EDITORIAL; HUMAN; LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE; SEX RATIO; SURVIVAL;

HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MELANOMA; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 28844496329     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.07000.x     Document Type: Editorial

References (20)

1. Gutzmer R, Al-Ghazal M, Geerlings H, Kapp A. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival - a retrospective analysis of 673 patients. Br J Dermatol 2005; 153:1137-1141.
2. Meier F, Will S, Ellwanger U et al. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol 2002; 47:62-70.
3. Russell-Jones R, Powell AM, Acland K et al. The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB). Eur J Surg Oncol 2005; 31:210-11.
4. Veronesi U, Adamus J, Bandiera D et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 1982; 49:2420-30.
5. Sim F, Taylor W, Pritchard D, Soule E. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomised study. Mayo Clin Proc 1986; 61:697-705.
6. Balch C, Soong S, Barolucci A et al. Efficacy of an elective regional lymph node dissection of 1-4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996; 244:255-63.
7. Cascinelli N, Morabito A, Santinami M et al. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 1998; 351:793-6.
8. Morton DL, Wen DR, Wong JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392-9.
9. Morton DL, Hoon DS, Cochran AJ et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 2003; 238:538-49.
10. Morton DL, Thompson JF, Essner R et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early stage melanoma: a multicenter trial - Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999; 230:453-63.
11. Morton DL, Thompson J, Cochran AJ et al. Lymphadenectomy Trial (MSLT-1) in clinical stage I melanoma. ASCO Annual Meeting, May 2005; Abstract 7500 (http://www.asco.org/ac/1,1003,_12-002511-00-18-0034-00-19-003013,00.asp).
12. Powell AM, Calonje E, Acland K et al. Pattern of clinical recurrence in patients with malignant melanoma and negative sentinel node biopsies. Br J Dermatol 2004; 151 (Suppl. 68):82-3 (Abstract).
13. Ling-Xi L, Scolyer R, Ka VS. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence. A clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol 2003; 27:1197-202.
14. Cook MG, Green MA, Anderson B et al. EORTC Melanoma Group. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 2003; 200:314-19.
15. Thompson JF. The Sydney Melanoma Unit experience of sentinel lymphadenectomy for melanoma. Ann Surg Oncol 2001; 8 (Suppl. 9): 44-7.
16. Thomas J, Patocskai E. The argument against sentinel node biopsy for malignant melanoma. BMJ 2000; 321:3-4.
17. Thomas J, Clark M. Selective lymphadenectomy in sentinel node positive patients may increase the risk of local/in transit recurrence in malignant melanoma. Eur J Surg. Oncol 2004; 30:686-91.
18. Roberts DLL, Anstey AV, Barlow RJ et al. U.K. guidelines for the management of cutaneous melanoma. Br J Dermatol 2002; 146:7-17.
19. Kirkwood JM, Manola J, Ibrahim J et al. Eastern Cooperative Oncology Group. A pooled analysis of Eastern Cooperative Oncology Group and intergroup trials of adjuvant high-dose interferon for melanoma. Clin Cancer Res 2004; 10:1670-7.
20. Wrightson W, Wong S, Edwards M et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol 2003; 10:676-80.